<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>AIM: To investigate Glyoxalase I and <z:chebi fb="0" ids="24103">fructosamine</z:chebi>-3-kinase (FN3K) activity in red blood cells from patients with colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: Thirty three consecutive subjects with one or more histologically confirmed colorectal <z:mpath ids='MPATH_490'>adenomatous polyps</z:mpath>, 16 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> patients and a group of 11 control subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> colonoscopy were included in the study </plain></SENT>
<SENT sid="2" pm="."><plain>Glyoxalase I and FN3K activities were measured in red blood cells using a spectrophotometric and radiometric assay, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: A significant reduction in both Glyoxalase I and FN3K activity was detected in patients with <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> compared to patients with <z:mpath ids='MPATH_270'>adenomas</z:mpath> and the controls </plain></SENT>
<SENT sid="4" pm="."><plain>Erythrocyte Glyoxalase I activity in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> was approximately 6 times lower than that detected in patients with <z:mpath ids='MPATH_270'>adenoma</z:mpath> (0.022 ± 0.01 mmol/min per milliliter vs 0.128 ± 0.19 mmol/min per milliliter of red blood cells, P = 0.003, Tukey's test) </plain></SENT>
<SENT sid="5" pm="."><plain>FN3K activity in red blood cells from patients with <z:hpo ids='HP_0003003'>colon cancer</z:hpo> was approximately 2 times lower than that detected in <z:mpath ids='MPATH_270'>adenoma</z:mpath> patients (19.55 ± 6.4 pmol/min per milliliter vs 38.6 ± 31.7 pmol/min per milliliter of red blood cells, P = 0.04, Tukey's test) </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSION: These findings suggest that deglycating enzymes may be involved in the <z:e sem="disease" ids="C1608408" disease_type="Neoplastic Process" abbrv="">malignant transformation</z:e> of colon mucosa </plain></SENT>
</text></document>